In this study, we identified the direct regulation of PD-L1 and B7-H3 expression by miR-326 and the subsequent suppression of CD8+ T cells in the tumor microenvironment and highlighted a new potential therapeutic target to overcome immune evasion by tumor cells. This evidence concerns the gene CD276 and neoplasm.